Drug Development Insights Adds Depth to Research Expertise to Better Serve Bio-Pharmaceutical Industry Executives

February 16, 2008 (PRLEAP.COM) Health News
Media, PA, USA – Drug Development Insights, a market research firm that provides strategic marketing information to pharmaceutical, biotechnology, medical device and diagnostics marketers, announced that Christopher Sutherland, PhD has joined the company as a Researcher and Consultant in a newly created position.

As an 18 year veteran of the healthcare market research industry, Dr. Sutherland brings significant pharmaceutical market research experience to Drug Development Insights. He has spent much of his career as a senior associate with full service, custom market research companies, including 12 years at TVG as a Vice President. Dr. Sutherland has advanced degrees in economic and marketing geography. He has taught research methods at the University level, and for Fortune 500 companies.

Dr. Sutherland has successfully helped clients achieve their goals with products in development, for new/existing products, and products three to five years from launch. He has designed and managed strategic projects including market assessment, idea generation, positioning, branding and war games, as well as tactical projects such as message development, sales communication, and ad tests.

Chris Sutherland has 18 years of experience designing and conducting research with managed care. He has expertise in the areas of product assessment, pricing, contracting, access, relationship building, outcomes, disease management, and pharmacoeconomics.

“The addition of Chris to the team brings Drug Development Insights to a new level. With Chris’ expertise in both qualitative and quantitative research, we are now truly set up to partner with clients, addressing their full spectrum of market research needs.” said Ross Weaver. “Chris’ deep and varied experience will be instrumental in our continued mission to provide our clients with unmatched market research insights.”

“I’m excited to be joining Dr. Ross Weaver and the DDI team,” said Sutherland. “My expertise in the design and conduct of custom research to meet the practical needs of clients, and my wide range of therapeutic area experience will complement Ross’ ability to provide valuable insights to add to companies’ successes.”

The team of Weaver and Sutherland delivers premium value to clients. Dr. Weaver, President of Drug Development Insights, works closely with clients to ensure that the key business issues are surfaced and crystallized, while Dr. Sutherland creates the optimal research approach to address those issues.

Drug Development Insights exclusively services pharmaceutical and biotechnology executives providing them with critical market analysis and assessments that help their companies improve their business results. Drug Development Insights primarily serves executives responsible for New Product Planning, Market Research, and Business Development. For more information about Drug Development Insights, visit www.ddinsights.com .